Holders of warrants for 2,790,340 shares exercised after the price fell from $2.86 to $1.60 and received new warrants for 5,580,680 shares. Roth Capital Partners acted as financial advisor.
Holders of warrants for 837,104 shares agreed to exercise at $4.42 per share and receive new warrants at $3.75. Roth Capital Partners acted as financial advisor.
Creative Medical Technology Holdings annual financials
Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $8.7 million.
Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.
Questions about Creative Medical Technology Holdings
What is the ticker symbol of Creative Medical Technology Holdings?
Creative Medical Technology Holdings, Inc. trades under the ticker CELZ on NASDAQ.
Where is Creative Medical Technology Holdings listed?
Creative Medical Technology Holdings, Inc. is listed on NASDAQ.
What is the SEC CIK of Creative Medical Technology Holdings?
The SEC Central Index Key (CIK) for Creative Medical Technology Holdings, Inc. is 1187953. Its filings are on SEC EDGAR.
How many shares does Creative Medical Technology Holdings have outstanding?
6,592,557 shares as of 2026-08-07, per the cover page of its 10-Q filed 2026-08-07.
Which country or territory is Creative Medical Technology Holdings listed under?
Our directory records Creative Medical Technology Holdings, Inc. under United States.
What does Creative Medical Technology Holdings do?
Our directory classifies Creative Medical Technology Holdings, Inc. as: Biopharma / pharmaceuticals. This is a directory classification, not a description of the pipeline.
What is the ISIN of Creative Medical Technology Holdings?
The ISIN recorded for Creative Medical Technology Holdings, Inc. is US22529Y4089.
Does aibio.space cover Creative Medical Technology Holdings?
aibio.space lists Creative Medical Technology Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Creative Medical Technology Holdings incorporated?
SEC records list its state or country of incorporation as NV.
What was Creative Medical Technology Holdings's revenue last year?
$6,000 for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Creative Medical Technology Holdings profitable?
Creative Medical Technology Holdings, Inc. reported a net loss of $6.0 million for the fiscal year ended Dec 31, 2025, and used $5.9 million of cash in operations, per its annual report to the SEC.
How much does Creative Medical Technology Holdings spend on research and development?
$2.3 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Creative Medical Technology Holdings have?
$8.7 million in cash at Jun 30, 2026, per its 10-Q.
What is the latest Creative Medical Technology Holdings (CELZ) stock news?
Our latest story on Creative Medical Technology Holdings, dated Jul 2, 2026: "Creative Medical Technology gets $4.5 million from warrant exercise at reduced $1.60 price". Holders of warrants for 2,790,340 shares exercised after the price fell from $2.86 to $1.60 and received new warrants for 5,580,680 shares. Roth Capital Partners acted as financial advisor. Source.
What is Creative Medical Technology Holdings's latest stock offering or financing news?
Our latest financing story, dated Jul 2, 2026: "Creative Medical Technology gets $4.5 million from warrant exercise at reduced $1.60 price". Holders of warrants for 2,790,340 shares exercised after the price fell from $2.86 to $1.60 and received new warrants for 5,580,680 shares. Roth Capital Partners acted as financial advisor. Source.
Investor discussion: Creative Medical Technology Holdings
Members talk about Creative Medical Technology Holdings (CELZ). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at Creative Medical Technology Holdings, newest first. Each line links the filing it comes from.
Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.03,5.07,9.01). Source
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,9.01). Source
Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.03,5.07,9.01). Source
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:CELZ on TradingView.
SEC filings and registration
SEC name
Creative Medical Technology Holdings, Inc.
CIK
1187953
Industry (SIC)
Biological Products, (No Diagnostic Substances) (2836)
US tickers
CELZ (Nasdaq)
State or country of incorporation
NV
Fiscal year ends
December 31
Filer category
Non-accelerated filer<br>Smaller reporting company
Business address
211 E. OSBORN RD., PHOENIX, AZ, 85012
Phone
480-399-2822
Shares outstanding
6,592,557 as of 2026-08-07 (10-Q filed 2026-08-07)
Former names
JOLLEY MARKETING INC
Recent filings (8-K and 6-K are the company's own announcements)
Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.
Listing details
Creative Medical Technology Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CELZ, recorded under United States. The directory classifies it as Biopharma / pharmaceuticals. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio